These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 3549395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of herd immunity in control of measles.
    Black FL.
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [Abstract] [Full Text] [Related]

  • 3. Measles active and passive immunity in a worldwide perspective.
    Black FL.
    Prog Med Virol; 1989; 36():1-33. PubMed ID: 2685909
    [Abstract] [Full Text] [Related]

  • 4. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.
    J Infect Dis; 2004 Jul 01; 190(1):83-90. PubMed ID: 15195246
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S, Sanders RC, Alpers MP.
    J Trop Med Hyg; 1991 Apr 01; 94(2):88-91. PubMed ID: 2023293
    [Abstract] [Full Text] [Related]

  • 7. Population immunity to measles in the United States, 1999.
    Hutchins SS, Bellini WJ, Coronado V, Jiles R, Wooten K, Deladisma A.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [Abstract] [Full Text] [Related]

  • 8. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK, Singhal PK, Khare S, Kumari S, Mathur R, Mullick DN.
    Indian Pediatr; 1989 Aug 01; 26(8):765-72. PubMed ID: 2620977
    [Abstract] [Full Text] [Related]

  • 9. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N, Uzel N, Gökçay G, Kiliç A, Yilmaz G, Sadikoğlu B, Diri S.
    Pediatr Infect Dis J; 2003 Aug 01; 22(8):691-5. PubMed ID: 12913768
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
    Helfand RF, Witte D, Fowlkes A, Garcia P, Yang C, Fudzulani R, Walls L, Bae S, Strebel P, Broadhead R, Bellini WJ, Cutts F.
    J Infect Dis; 2008 Nov 15; 198(10):1457-65. PubMed ID: 18828743
    [Abstract] [Full Text] [Related]

  • 11. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.
    Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG, Toureau S, Rohde J, Boulos C.
    N Engl J Med; 1985 Aug 29; 313(9):544-9. PubMed ID: 4022091
    [Abstract] [Full Text] [Related]

  • 12. The evaluation of vaccination against measles at nine months of age (report of an epidemic).
    Ceyhan M, Kanra G, Vargel S, Işikçelik Y.
    Turk J Pediatr; 1992 Aug 29; 34(3):127-33. PubMed ID: 1485379
    [Abstract] [Full Text] [Related]

  • 13. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA, Harry TO.
    Trop Geogr Med; 1981 Dec 29; 33(4):379-82. PubMed ID: 7342385
    [Abstract] [Full Text] [Related]

  • 14. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS, Redd SC, Schrag S, Kruszon-Moran D, Wooten K, McQuillan GM, Bellini W, Meyer PA, Hadler S.
    MedGenMed; 2001 Jan 24; ():E5. PubMed ID: 11320344
    [Abstract] [Full Text] [Related]

  • 15. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E, Urbiztondo L, Costa J, Batalla J, Torner N, Plasencia A, Salleras L, Domínguez À, Working Group for the Study of Measles Immunity in Children.
    Epidemiol Infect; 2012 Sep 24; 140(9):1599-606. PubMed ID: 22074684
    [Abstract] [Full Text] [Related]

  • 16. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM.
    J Med Virol; 1997 Jan 24; 51(1):32-5. PubMed ID: 8986946
    [Abstract] [Full Text] [Related]

  • 17. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO, Ogunmekan DA.
    Trop Geogr Med; 1981 Dec 24; 33(4):375-8. PubMed ID: 7342384
    [Abstract] [Full Text] [Related]

  • 18. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC, Dine MS, Roselle GA, Askey PA.
    Pediatrics; 1982 Mar 24; 69(3):332-5. PubMed ID: 7063289
    [Abstract] [Full Text] [Related]

  • 19. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY, Feng ZX, Xu AQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct 24; 16(5):263-5. PubMed ID: 8706090
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G, Boulianne N, Ratnam S, Corriveau A.
    Pediatrics; 1996 Feb 24; 97(2):232-5. PubMed ID: 8584383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.